Travere Therapeutics shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Travere Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Travere Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Travere Therapeutics by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $6.4M | 779k | 8.22 |
| 2024-03-31 | $5.5M | 719k | 7.71 |
| 2023-12-31 | $13M | 1.5M | 8.99 |
| 2023-09-30 | $14M | 1.5M | 8.94 |
| 2023-06-30 | $14M | 924k | 15.36 |
| 2023-03-31 | $18M | 791k | 22.49 |
| 2022-12-31 | $56M | 2.6M | 21.03 |
| 2022-06-30 | $63M | 2.6M | 24.23 |
| 2022-03-31 | $67M | 2.6M | 25.77 |
| 2021-12-31 | $81M | 2.6M | 31.04 |
| 2021-09-30 | $27M | 1.1M | 24.25 |
| 2021-03-31 | $21M | 827k | 24.97 |
| 2020-12-31 | $20M | 714k | 27.25 |